Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug-Eluting Stents | 2 | 2014 | 13 | 0.840 |
Why?
|
| Prosthesis Failure | 2 | 2014 | 45 | 0.760 |
Why?
|
| Anticoagulants | 2 | 2019 | 123 | 0.740 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2018 | 83 | 0.690 |
Why?
|
| Stroke | 4 | 2019 | 584 | 0.630 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 8 | 0.630 |
Why?
|
| Secondary Prevention | 1 | 2018 | 63 | 0.610 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 30 | 0.490 |
Why?
|
| Device Removal | 1 | 2014 | 33 | 0.480 |
Why?
|
| Stents | 3 | 2003 | 178 | 0.440 |
Why?
|
| Catheterization | 2 | 2009 | 58 | 0.380 |
Why?
|
| Coronary Thrombosis | 1 | 2009 | 14 | 0.350 |
Why?
|
| Endocarditis | 2 | 2020 | 15 | 0.350 |
Why?
|
| Heart Valve Prosthesis | 2 | 2007 | 55 | 0.340 |
Why?
|
| Patient Selection | 2 | 2008 | 277 | 0.330 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 7 | 0.330 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2003 | 70 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 1 | 2007 | 31 | 0.290 |
Why?
|
| Aortic Valve | 1 | 2007 | 49 | 0.290 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 39 | 0.290 |
Why?
|
| Palliative Care | 1 | 2007 | 52 | 0.290 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 27 | 0.280 |
Why?
|
| Angioplasty | 2 | 2004 | 34 | 0.270 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 401 | 0.260 |
Why?
|
| Carotid Stenosis | 2 | 2003 | 58 | 0.260 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 485 | 0.250 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2009 | 35 | 0.250 |
Why?
|
| Treatment Outcome | 8 | 2018 | 3317 | 0.250 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Time Factors | 4 | 2018 | 2152 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 200 | 0.220 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2003 | 15 | 0.220 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 30 | 0.220 |
Why?
|
| Tyrosine | 1 | 2003 | 23 | 0.220 |
Why?
|
| Dissection | 1 | 2003 | 17 | 0.220 |
Why?
|
| Humans | 20 | 2020 | 32024 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 233 | 0.220 |
Why?
|
| Risk Assessment | 3 | 2018 | 1435 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 291 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 245 | 0.210 |
Why?
|
| Peptides | 1 | 2003 | 119 | 0.210 |
Why?
|
| Aortic Diseases | 1 | 2003 | 63 | 0.200 |
Why?
|
| Quality of Life | 1 | 2007 | 932 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 244 | 0.190 |
Why?
|
| Aging | 1 | 2007 | 945 | 0.190 |
Why?
|
| Radiography | 2 | 2014 | 377 | 0.190 |
Why?
|
| Aged | 11 | 2020 | 10340 | 0.180 |
Why?
|
| Drug Users | 1 | 2020 | 10 | 0.180 |
Why?
|
| Injections | 1 | 2020 | 64 | 0.180 |
Why?
|
| Female | 13 | 2020 | 19953 | 0.170 |
Why?
|
| Middle Aged | 11 | 2020 | 11868 | 0.170 |
Why?
|
| Male | 12 | 2020 | 19195 | 0.170 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 33 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 942 | 0.170 |
Why?
|
| Adult | 7 | 2020 | 9366 | 0.160 |
Why?
|
| Risk Factors | 3 | 2018 | 3869 | 0.150 |
Why?
|
| Recurrence | 1 | 2018 | 265 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2003 | 785 | 0.150 |
Why?
|
| Renal Artery Obstruction | 2 | 2008 | 41 | 0.150 |
Why?
|
| Hospitalization | 1 | 2020 | 470 | 0.140 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 35 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 507 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 900 | 0.130 |
Why?
|
| Coronary Disease | 2 | 2007 | 213 | 0.130 |
Why?
|
| Coronary Restenosis | 1 | 2014 | 13 | 0.120 |
Why?
|
| North Carolina | 3 | 2020 | 1516 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2016 | 897 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2020 | 3523 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2009 | 48 | 0.080 |
Why?
|
| Fluoroscopy | 1 | 2009 | 40 | 0.080 |
Why?
|
| Femoral Artery | 1 | 2009 | 50 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2009 | 130 | 0.080 |
Why?
|
| Equipment Design | 1 | 2008 | 172 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2007 | 97 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2007 | 46 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 47 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 4000 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2008 | 673 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2008 | 379 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 181 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 565 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 407 | 0.060 |
Why?
|
| Leg | 1 | 2005 | 66 | 0.060 |
Why?
|
| Infant | 1 | 2008 | 1061 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 51 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2008 | 1269 | 0.060 |
Why?
|
| Middle Cerebral Artery | 1 | 2004 | 13 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 35 | 0.060 |
Why?
|
| Age Factors | 1 | 2007 | 1194 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2003 | 24 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 39 | 0.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2003 | 49 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 74 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2003 | 83 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2008 | 767 | 0.050 |
Why?
|
| Child | 1 | 2008 | 2441 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 1831 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2020 | 32 | 0.040 |
Why?
|
| Heart Failure | 1 | 2005 | 636 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2009 | 2283 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2615 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 2280 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 1125 | 0.020 |
Why?
|
| Palpation | 1 | 2009 | 9 | 0.020 |
Why?
|
| Hematoma | 1 | 2009 | 27 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 80 | 0.020 |
Why?
|
| American Heart Association | 1 | 2008 | 87 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 66 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 771 | 0.020 |
Why?
|
| Argentina | 1 | 2005 | 5 | 0.020 |
Why?
|
| Germany | 1 | 2005 | 6 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2007 | 526 | 0.020 |
Why?
|
| Incidence | 1 | 2009 | 1200 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2007 | 544 | 0.020 |
Why?
|
| Observer Variation | 1 | 2005 | 105 | 0.020 |
Why?
|
| Diastole | 1 | 2005 | 96 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2005 | 294 | 0.020 |
Why?
|
| Patient Admission | 1 | 2005 | 60 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2005 | 152 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 594 | 0.020 |
Why?
|
| Ischemia | 1 | 2005 | 98 | 0.020 |
Why?
|
| Retreatment | 1 | 2004 | 41 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 251 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2004 | 63 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 163 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 687 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2003 | 24 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 84 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 981 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2005 | 349 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 845 | 0.010 |
Why?
|
| United States | 1 | 2008 | 3938 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 918 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 7466 | 0.010 |
Why?
|